Alvin Shih's most recent trade in Zevra Therapeutics Inc was a trade of 20,000 Common Stock done at an average price of $7.9 . Disclosure was reported to the exchange on Sept. 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zevra Therapeutics Inc | Alvin Shih | Director | Purchase of securities on an exchange or from another person at price $ 7.89 per share. | 12 Sep 2025 | 20,000 | 20,000 (0%) | 0% | 7.9 | 157,800 | Common Stock |
| Zevra Therapeutics Inc | Alvin Shih | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Zevra Therapeutics Inc | Alvin Shih | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 39,200 | 39,200 | - | - | Stock Option (right to buy) | |
| Zevra Therapeutics Inc | Alvin Shih | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2024 | 58,800 | 58,800 | - | - | Stock Option (right to buy) |